Trial intelligence / Profile preview

Intrathecal dexmedetomidine and core temperature/shivering during spinal anesthesia for cesarean section

IRCT201511301766N7Phase 3Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in Shivering and Hypothermia, sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Change in core body temperature and Incidence and severity of shivering. Started Dec 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

ShiveringHypothermia

Beyond the preview

Go deeper on IRCT201511301766N7.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201511301766N7.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call